Gabapentin Capsule
Product Images NDC 64380-753

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 64380-753). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (66c3584b 21d1 450a 8bfe Ba096129b91a 01)

An illustration showing the formula for calculating creatinine clearance (CLCr), including variables for age, weight, serum creatinine, and a factor for female patients. The formula is presented as (140 - age in years) times weight in kilograms, divided by 72 times serum creatinine in mg/dL, multiplied by 0.85 for female patients.*

FDA Label Image

Figure1 (66c3584b 21d1 450a 8bfe Ba096129b91a 02)

Chemical structure of gabapentin showing a cyclohexane ring attached to a structure with an amino group (CH2NH2) and a carboxylic acid group (CH2CO2H).*

FDA Label Image

Image 1 (66c3584b 21d1 450a 8bfe Ba096129b91a 03)

A line graph showing mean pain scores over 8 weeks, comparing placebo and gabapentin 3600 mg/day. The x-axis represents weeks from baseline to week 8, and the y-axis shows mean pain scores from 0 to 10. The graph indicates a 4-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Image 2 (66c3584b 21d1 450a 8bfe Ba096129b91a 04)

A line graph showing mean pain scores over 7 weeks for placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day groups. The x-axis represents weeks from baseline through week 7, including a 3-week dose titration period and a 4-week fixed dose period. The y-axis represents mean pain scores from 0 to 10, with Gabapentin groups showing a decrease in pain scores over time compared to placebo.*

FDA Label Image

Image 3 (66c3584b 21d1 450a 8bfe Ba096129b91a 05)

A bar graph titled 'Figure 3. Proportion of Responders (patients with a 50% reduction in pain score) at Endpoint: CONDUCT PHN Studies.' It compares responder proportions across placebo (PBO) and Gabapentin (GBP) doses in two studies, showing percentages on the vertical axis and treatment groups on the horizontal axis.*

FDA Label Image

Image 4 (66c3584b 21d1 450a 8bfe Ba096129b91a 06)

A scatter plot chart showing differences (%) on the vertical axis and daily dose (mg) on the horizontal axis. It compares results from three studies labeled a, b, and c, with distinct markers indicating data points at various doses ranging from 600 mg to 1800 mg.*

FDA Label Image

Gaba-100mg (66c3584b 21d1 450a 8bfe Ba096129b91a 07)

Gabapentin Capsules, USP 100 mg oral capsules label by Strides Pharma Inc. The label states each capsule contains 100 mg Gabapentin USP and contains 100 capsules. Storage instructions specify 20° to 25°C with allowable excursions, and a child-resistant container is recommended. It includes a barcode and medication guide URL, with a revision date of 01/2025.*

FDA Label Image

Gaba-300mg (66c3584b 21d1 450a 8bfe Ba096129b91a 08)

Gabapentin Capsules, USP 300 mg label from Strides Pharma Science Limited. The label states each capsule contains 300 mg of Gabapentin. It includes storage instructions, dispensing guidelines, and a warning to keep medications out of children's reach. The package contains 100 capsules and is marked Rx only. The label features distributor information and a barcode.*

FDA Label Image

Gaba-500mg (66c3584b 21d1 450a 8bfe Ba096129b91a 09)

Label for Gabapentin Capsules, USP 400 mg by Strides Pharma Science Limited. The label includes dosage strength (400 mg), package count (100 capsules), storage instructions, and a pharmacist's note to dispense the medication guide separately. Distributed by Strides Pharma Inc., East Brunswick, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.